April 23, 2017 9:38 AM ET

Biotechnology

Company Overview of Hookipa Biotech GmbH

Company Overview

Hookipa Biotech GmbH develops genetic vaccines for the prophylactic and therapeutic treatment of viral diseases. The company’s technology platform, Vaxwave, provides long lasting and potent stimulation of both cellular and humoral immunity. Hookipa Biotech GmbH was founded in 2011 and is based in Vienna, Austria.

Julius-Raab-Platz 4

Vienna,  1010

Austria

Founded in 2011

Key Executives for Hookipa Biotech GmbH

Chief Executive Officer
Age: 57
Compensation as of Fiscal Year 2016.

Hookipa Biotech GmbH Key Developments

Hookipa Biotech GmbH Presents at Sachs Associates 10th Annual European Life Sciences CEO Forum & Exhibition, Mar-06-2017 through Mar-07-2017

Hookipa Biotech GmbH Presents at Sachs Associates 10th Annual European Life Sciences CEO Forum & Exhibition, Mar-06-2017 through Mar-07-2017. Venue: Hilton Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Switzerland. Presentation Date & Speakers: Mar-06-2017. Mar-07-2017, Joern Aldag, Chief Executive Officer.

Hookipa Biotech GmbH Presents at BD Boston, Mar-09-2017 12:50 PM

Hookipa Biotech GmbH Presents at BD Boston, Mar-09-2017 12:50 PM. Venue: The Colonnade Hotel, 120 Huntington Avenue, Boston, MA 02116, United States. Speakers: Torsten Mummenbrauer, SVP, BD.

Hookipa Biotech AG Announces Executive Changes

Hookipa Biotech AG announced the appointment of Mr. Jörn Aldag as CEO. Mr. Aldag brings significant leadership experience and sector knowledge to Hookipa from leading biotechnology companies including uniQure, Molecular Partners and Unum Therapeutics. In particular, he has an impressive track record of building companies based on unique technology platforms, and bringing them to public markets in order to access the depth of capital needed to develop clinical stage assets. Alongside his CEO role at Hookipa Mr. Aldag will remain Chairman of Molecular Partners and a Board member of Unum Therapeutics, both of which are developing next-gen immuno-oncology therapies. Mr. Aldag replaces Dr. Katherine Cohen, who started the Company in 2011 and led its development from early science to clinical stage.

Similar Private Companies By Industry

Company Name Region
Activartis Biotech GmbH Europe
APEIRON Biologics AG Europe
Apeptico Forschung und Entwicklung GmbH Europe
Aposcience AG Europe
ARTMA Medical Technologies AG Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Hookipa Biotech GmbH, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.